Epidermal growth factor (EGF), which is produced in abundance by salivary glands, is a multifunctional factor known to influence the proliferation, differentiation, and physiological function of a wide variety of cell types (reviewed in Ref. 5). The actions of EGF are mediated via a receptor tyrosine kinase cascade, leading to a number of signaling events including activation of PKC and the mitogen-activated protein kinase (MAP kinase) pathway (7, 21) . Previous studies implicate interaction, or "cross talk," between EGF-induced signals and other signaling pathways. For example, EGF modulates G protein-coupled receptor activation of adenylyl cyclase in a number of tissues (10); purinergic receptor-induced calcium signaling also appears to be influenced by EGF (13). In salivary glands, EGF modifies muscarinic agonist-mediated amylase secretion (29). Although this finding suggests a role for EGF in the regulation of muscarinic receptor function in salivary cells, to our knowledge no previous investigations have demonstrated an interaction between EGF and muscarinic signaling pathways. In the present study, we have used HSY cells, a ductal cell line from human parotid (42), as a model system to determine whether the EGF receptor tyrosine kinase cascade modulates muscarinic receptor signaling in salivary cells. Our results indicate that EGF inhibits musca-
, was decreased by 20% after EGF treatment. Inhibition of the carbachol response by EGF was not altered by phorbol ester-induced downregulation of protein kinase C (PKC) but was enhanced upon PKC activation by a diacylglycerol analog. Phosphorylation of mitogen-activated protein kinase (MAP kinase) and inhibition of the carbachol response by EGF were both blocked by the MAP kinase pathway inhibitor PD-98059. The results suggest that EGF decreases carbachol-induced Ca 2ϩ release from internal stores and also exerts a direct inhibitory action on Ca 2ϩ influx. A decline in muscarinic receptor density may contribute to EGF inhibition of carbachol responsiveness. The inhibitory effect of EGF is mediated by the MAP kinase pathway and is potentiated by a distinct modulatory cascade involving activation of PKC. EGF may play a physiological role in regulating muscarinic receptor-stimulated salivary secretion.
carbachol; signal transduction; protein kinase C; mitogenactivated protein kinase; epidermal growth factor FLUCTUATIONS of intracellular calcium ([Ca 2ϩ ] i ) mediate the cellular actions of many neurotransmitters, hormones, and growth factors. In salivary gland cells, activation of G protein-coupled muscarinic-cholinergic receptors results in hydrolysis of phosphatidylinositol 4,5-bisphosphate, yielding diacylglycerol and inositol 1,4,5-trisphosphate (IP 3 ). Diacylglycerol is an endogenous activator of protein kinase C (PKC). IP 3 induces calcium release from internal calcium stores, followed by the entry of extracellular Ca 2ϩ and a sustained elevation of [Ca 2ϩ ] i (2) . The mobilization of [Ca 2ϩ ] i in salivary cells is directly related to the level of fluid secretion (30) . Currently, factors modulating the muscarinic receptor-coupled calcium signaling pathway in salivary cells have not been well characterized.
Epidermal growth factor (EGF), which is produced in abundance by salivary glands, is a multifunctional factor known to influence the proliferation, differentiation, and physiological function of a wide variety of cell types (reviewed in Ref. 5 ). The actions of EGF are mediated via a receptor tyrosine kinase cascade, leading to a number of signaling events including activation of PKC and the mitogen-activated protein kinase (MAP kinase) pathway (7, 21) . Previous studies implicate interaction, or "cross talk," between EGF-induced signals and other signaling pathways. For example, EGF modulates G protein-coupled receptor activation of adenylyl cyclase in a number of tissues (10); purinergic receptor-induced calcium signaling also appears to be influenced by EGF (13) . In salivary glands, EGF modifies muscarinic agonist-mediated amylase secretion (29) . Although this finding suggests a role for EGF in the regulation of muscarinic receptor function in salivary cells, to our knowledge no previous investigations have demonstrated an interaction between EGF and muscarinic signaling pathways. In the present study, we have used HSY cells, a ductal cell line from human parotid (42) , as a model system to determine whether the EGF receptor tyrosine kinase cascade modulates muscarinic receptor signaling in salivary cells. Our results indicate that EGF inhibits musca-rinic receptor-mediated [Ca 2ϩ ] i mobilization in HSY cells by activation of the MAP kinase pathway.
MATERIALS AND METHODS

Materials.
Recombinant human EGF (rhEGF), insulin-like growth factor I (rhIGF-I), and transforming growth factor-␣ (rhTGF-␣) were purchased from Promega (Madison, WI); platelet-derived growth factor (rhPDGF-AB) was from Peprotech (Rocky Hill, NJ). Fura 2-AM was from Molecular Probes (Eugene, OR). Thapsigargin, 2-(2Ј-amino-3Ј-methoxyphenyl)-oxanaphthalen-4-one (PD-98059), and digitonin were purchased from RBI (Natick, MA). Monoclonal anti-PKC antibody (which recognizes ␣-and ␤-isoforms of PKC) was from Amersham (Arlington Heights, IL). Antibodies against p44/42 MAP kinase and phospho-p44/42 MAP kinase were purchased from New England Biolabs (Beverly, MA). Cell culture. The HSY cell line was originally established by Yanagawa et al. (42) and was kindly provided by Dr. James Turner (NIDCR/NIH, Bethesda, MD). Cells were plated at a density of about 2 ϫ 10 4 cells/cm 2 in 60-or 100-mm culture dishes and cultured in DMEM supplemented with 10% fetal calf serum and penicillin (100 U/ml)/streptomycin (100 g/ml) at 37°C in a humidified 5% CO 2 atmosphere incubator. Cells were grown to near confluence at 72 h and were then harvested with trypsin (0.05%)-EDTA (0.02%) for [Ca 2ϩ ] i and receptor binding measurements. Unless otherwise specified, EGF and other growth factors (TGF-␣, PDGF, or IGF-I) were added 48 h prior to confluence, i.e., 24 h after plating. Addition of EGF caused a small but significant increase in cell number (ϳ9% increase; P Ͻ 0.001) at 72 h.
Measurement of intracellular calcium. [Ca 2ϩ ] i was determined by spectrofluorometric measurements in cell suspensions. HSY cells were loaded with 1.2 M fura 2-AM in a high-salt glucose (HNG) buffer containing 140 mM NaCl, 5 mM KCl, 1 mM CaCl 2 , 1 mM MgSO 4 , 1.2 mM KH 2 PO 4 , 10 mM glucose, and 10 mM HEPES, pH 7.4, at 37°C for 30-45 min with gentle shaking (43) . Loaded cells were washed with fresh buffer to remove the extracellular dye and resuspended in HNG or Ca 2ϩ -free HNG, as required for individual experiments, at a density of 10 6 cells/ml. The Ca 2ϩ -free HNG medium contained 100 M EGTA instead of 1 mM CaCl 2 . Fura 2-loaded cells were then exposed to the muscarinic agonist carbachol or other stimulatory agents at 37°C.
Excitation ratio of 340/380 was measured with a PTI Delta Scan spectrofluorometer (Photon Technology International, South Brunswick, NJ) using 340-nm and 380-nm wavelengths for excitation and 510 nm for emission (25) . [Ca 2ϩ ] i values were calculated according to the equation [Ca 2ϩ 
, where R is the fluorescent ratio of 340/380; R min and R max are minimal and maximal fluorescent ratios, respectively; and the K d is the dissociation constant (taken as 224 nM) of fura 2 for Ca 2ϩ (9) . At the end of each experiment, R max was determined by adding 5 M digitonin to the cell suspension, and R min was achieved by chelating Ca 2ϩ with 10 mM EGTA. Immunoblot analysis of MAP kinase. Immunoblot analysis of MAP kinase was performed essentially as described previously (18) . Briefly, confluent HSY cells were washed twice with PBS at 4°C and scraped in 1-2 ml homogenization buffer containing 20 mM Tris, 10 mM KCl, 2 mM EDTA, 0.5 mM EGTA, 2.5 g/ml leupeptin, 10 g/ml aprotinin, 0.2 mM phenylmethylsulfonyl fluoride (PMSF), and 1 mM sodium orthovanadate (Na 3 VO 4 ), pH 7.5. The cells were homogenized in a 1.5-ml tissue grinder (Kontes Duall, from Fisher Scientific) with 30 strokes on ice. The homogenate was centrifuged (1,000 g at 4°C) for 10 min, and supernatant proteins (20 g) were separated on 10% SDS-PAGE gels and transferred to polyvinylidene difluoride membranes (Schleicher & Schuell, Keene, NH). The membranes were immunoblotted with p44/p42 MAP kinase or phospho-p44/p42 MAP kinase primary antibody (1:1,000) and secondary antibody (1:1,000) conjugated to horseradish peroxidase (Amersham). MAP kinases were visualized by an enhanced chemiluminescence system (ECL Plus, Amersham) and quantified by a phosphorimager system (Storm 860; Molecular Dynamics, Sunnyvale, CA (34) .
RESULTS
Attenuation of carbachol-induced [Ca 2ϩ
] i mobilization by EGF. Figure 1A ] i mobilization was dependent on EGF concentration and time of incubation with the growth factor (Fig. 2) . The concentration of EGF producing half-maximal inhibition of carbachol response was 1.9 Ϯ 0.2 ϫ 10 Ϫ10 M. Inhibition of the carbachol-induced [Ca 2ϩ ] i signal was observed within about 2 h of EGF treatment, whereas the time of incubation required for maximal inhibition was 4-8 h.
To determine whether growth factor inhibition of carbachol-induced [Ca 2ϩ ] i mobilization is specific to EGF, we compared carbachol responses in HSY cells treated with EGF and other growth factors (TGF-␣, PDGF, and IGF-I) known to act through receptor tyrosine kinase pathways. TGF-␣ binds and activates EGF receptors (5), whereas PDGF and IGF-I activate tyrosine kinase signaling via their own distinct receptors. Like EGF, TGF-␣ also decreased carbachol-induced [Ca 2ϩ ] i mobilization in HSY cells. In contrast, PDGF and IGF-I did not alter carbachol responsiveness (Fig. 3) (Fig. 4) ; this apparent Ca 2ϩ influx was also significantly reduced by EGF (ϩEGF, 586 Ϯ 111 nM vs. ϪEGF, 885 Ϯ 106 nM; P Ͻ 0.05) (Fig. 4) . These findings suggest that EGF inhibition of carbachol-induced [Ca 2ϩ ] i mobilization in HSY cells (Fig. 1) -free conditions, thapsigargin produced equivalent increases in [Ca 2ϩ ] i in both EGF-treated and untreated HSY cells (Fig. 5) , suggesting that the growth factor does not alter the internal pool. Interestingly, whereas subsequent addition of Ca 2ϩ to the medium increased [Ca 2ϩ ] i , this response to extracellular Ca 2ϩ was significantly diminished in EGF-treated cells (ϩEGF, 702 Ϯ 55 nM vs. ϪEGF, 908 Ϯ 42 nM; P Ͻ 0.03) (Fig. 5) . The observation that EGF decreases the [Ca 2ϩ ] i response to extracellular Ca 2ϩ repletion without affecting the internal stores suggests a direct inhibitory effect of EGF on Ca 2ϩ influx. (Fig. 6) . Thus EGF inhibition of carbachol-induced [Ca 2ϩ ] i mobilization could be mediated at least partly by a reduction in muscarinic receptor density. EGF. As shown in Fig. 7, EGF completely ] i signal is not likely to mediate inhibition of the carbachol response observed after prolonged EGF treatment.
Another important signaling cascade activated by the EGF receptor tyrosine kinase is the MAP kinase pathway, which plays an essential role in mediating cellular responses to EGF and a variety of other growth factors (21) . In HSY cells, phosphorylation of MAP kinase by EGF was determined using immunoblot analysis. EGF induced the phosphorylation of the p44 isoform of MAP kinase without affecting the protein level. Treatment of HSY cells with PD-98059 (5 ϫ 10 Ϫ5 M), a synthetic inhibitor of the MAP kinase pathway (1), blocked EGF-induced phosphorylation of p44 MAP kinase (Fig. 9A) . As shown in Fig. 9B , inhibition of carbachol-stimulated [Ca 2ϩ ] i mobilization by EGF was prevented by PD-98059. These results suggest that the inhibitory effect of EGF on the carbachol response in HSY cells is mediated by activation of the MAP kinase pathway.
DISCUSSION
The results of the present study demonstrate a novel role for EGF in the regulation of muscarinic receptorcoupled [Ca 2ϩ ] i signaling in a human salivary cell line (HSY). We found that EGF inhibited carbachol-responsive [Ca 2ϩ ] i mobilization in a concentration-and timedependent manner ( Figs. 1 and 2 ). The [Ca 2ϩ ] i response to carbachol was decreased by both EGF and Identity of the p44 isoform of MAP kinase was determined by molecular weight markers. The p42 isoform of MAP kinase was not detectable in HSY cells, presumably because of low levels of expression; both p44 and p42 isoforms were detected in the C6 rat glioma cell line (not shown). EGF increased phosphorylation of p44 MAP kinase by 2,300 Ϯ 80% (P Ͻ 0.0001, n ϭ 5 experiments); PD-98059 inhibited EGF-induced phosphorylation by 53 Ϯ 5% (P Ͻ 0.0001). TGF-␣, which activate the EGF receptor, but not by growth factors (IGF-I and PDGF) acting on other receptor tyrosine kinases (Fig. 3) .
Inhibition of the carbachol response by EGF was observed in the absence of extracellular Ca 2ϩ (Fig. 4) , suggesting a modulatory action of the growth factor on release of Ca 2ϩ from carbachol-sensitive internal stores. The internal Ca 2ϩ pool, as reflected by the [Ca 2ϩ ] i response to thapsigargin in cells incubated without external Ca 2ϩ , was intact after EGF treatment (Fig. 5) . EGF has also been reported to have no effect on thapsigargin-sensitive Ca 2ϩ stores in a rat pheochromocytoma cell line (PC12) (13) . Therefore, inhibition of Ca 2ϩ release by EGF is likely to be exerted on one or more elements of the signaling pathway coupling activation of the muscarinic receptor to mobilization of the internal Ca 2ϩ store. Measurement of [ 3 H]QNB binding to HSY cell membranes revealed a small but significant decrease in muscarinic receptor density (B max ) after EGF treatment (Fig. 6 ). The loss of muscarinic receptor binding sites could be the result of alterations in receptor expression, posttranslational modifications, or desensitization mechanisms. Our data do not exclude actions of EGF on other elements of muscarinic receptor signaling, including receptor/G protein coupling, PLC-mediated generation of IP 3 , or activation of IP 3 -sensitive Ca 2ϩ release channels (IP 3 receptors) in the endoplasmic reticulum. In a variety of cell types, IP 3 receptor activity is regulated by tyrosine and serine/threonine phosphorylation (8, 15, 35, 44) . Whether EGF exerts direct or indirect effects on the phosphorylation characteristics of IP 3 receptors in HSY cells is not known.
Depletion of internal Ca 2ϩ stores activates influx of extracellular Ca 2ϩ across the plasma membrane in a process known as capacitative calcium entry (31) . This process is thought to be mediated by a plasma membrane Ca 2ϩ channel termed the "Ca 2ϩ release-activated Ca 2ϩ channel" (CRAC channel) or "store-operated Ca 2ϩ channel" (SOC channel) (45) . In HSY cells exposed to carbachol in the absence of extracellular Ca 2ϩ , we found that EGF decreased Ca 2ϩ influx following Ca 2ϩ repletion (Fig. 4) . Inhibition of Ca 2ϩ influx under these conditions could reflect either reduced Ca 2ϩ release, leading to less depletion of internal stores and a secondary decline in capacitative Ca 2ϩ entry, or a direct effect of EGF on Ca 2ϩ influx. Growth factor inhibition of Ca 2ϩ influx was also observed in cells treated with thapsigargin, even though EGF had no effect on thapsigargin-induced depletion of internal stores (Fig. 5) . Our findings therefore suggest that EGF not only inhibits muscarinic receptor-coupled Ca 2ϩ release but also modulates Ca 2ϩ influx independently of internal store depletion.
An inhibitory effect of EGF on Ca 2ϩ influx could be exerted directly on the Ca 2ϩ influx channel, although growth factor modification of as yet undefined signals coupling internal store depletion to Ca 2ϩ influx cannot be excluded. The CRAC channel protein(s) has yet to be identified but may be a mammalian homolog of one or more products of the trp (transient receptor potential) gene family in Drosophila photoreceptors. Six trp homologs (trp1-trp6) have been identified in a variety of mammalian tissues (45) , and a trp1 homologous sequence has been detected in rat submandibular gland RNA (40) . Calcium influx mediated by a mouse Trp6 protein appears to be stimulated by G protein-coupled receptors independently of internal Ca 2ϩ store depletion (4). Interestingly, a muscarinic receptor-activated Ca 2ϩ influx pathway resembling Ca 2ϩ entry through Trp6 has been described in a human submandibular gland cell line (HSG) (16) . Whether one or more Trp homologs mediate Ca 2ϩ influx in HSY cells has not yet been determined, and a role for EGF in regulating Trp channels in salivary or other cell types remains speculative.
Agonists binding to the EGF receptor modulate cellular functions by a complex series of signaling events, including activation of the MAP kinase and PKC pathways (7, 21) . In the present study EGF was found to induce phosphorylation of MAP kinase in HSY cells. Phosphorylation of MAP kinase and inhibition of carbachol-induced [Ca 2ϩ ] i mobilization by EGF were both blocked by PD-98059, a selective inhibitor of the MAP kinase pathway (Fig. 9) . In contrast, downregulation of PKC by prolonged exposure of HSY cells to phorbol ester had no effect on EGF inhibition of carbacholsensitive [Ca 2ϩ ] i mobilization (Fig. 7) . ] i response to carbachol following downregulation of PKC by phorbol ester, as well as a reduced [Ca 2ϩ ] i response after PKC activation by a diacylglycerol analog (Fig. 7) . These changes in [Ca 2ϩ ] i mobilization, although relatively small in magnitude and not statistically significant, suggest that PKC may exert an inhibitory effect on [Ca 2ϩ ] i signaling independent of the modulatory action of EGF. Activation of PKC in a number of cell types, including human salivary cells (HSG and HSY), is known to exert differential effects, both stimulatory and inhibitory, on Ca 2ϩ release responsive to muscarinic and other G proteincoupled receptors and also on capacitative Ca 2ϩ entry (3, 11, 19, 26, 27, 32, 41) . In addition, downregulation of several muscarinic receptor subtypes, occurring via phosphorylation-dependent receptor internalization or altered receptor gene transcription, is enhanced by PKC stimulation in various cell lines (33) . A particularly striking result of our own studies was the finding that the inhibitory effect of EGF on carbachol-stimulated [Ca 2ϩ ] i mobilization was greatly accentuated in HSY cells pretreated with the diacylglycerol analog (Fig. 7) . Whereas EGF alone inhibited the carbacholresponsive [Ca 2ϩ ] i signal by one-third, the carbachol response was completely blocked by the combination of growth factor and diacylglycerol analog (Fig. 7) . This marked synergy between the regulatory actions of an EGF receptor-activated, MAP kinase-dependent pathway and a distinct PKC activation cascade has not, to our knowledge, been described previously. Studies are currently underway in our laboratory to determine the cross talk mechanisms by which PKC potentiates EGF inhibition of carbachol-induced [Ca 2ϩ ] i signaling in HSY cells.
In this study EGF was found to exert two timedependent actions on [Ca 2ϩ ] i levels in HSY cells. Exposure of cells to EGF for prolonged periods (i.e., Ն 2 h) reduced carbachol-responsive [Ca 2ϩ ] i mobilization (Fig. 2B) , whereas a rapid increase in [Ca 2ϩ ] i occurred within seconds of EGF exposure in the absence of other [Ca 2ϩ ] i mobilizing agonists (Fig. 8) . Although both prolonged and rapid actions of EGF were concentration dependent, inhibition of carbachol responsiveness was observed at much lower concentrations of EGF than those required to cause rapid [Ca 2ϩ ] i mobilization (cf. Figs. 2A and 7) . The two effects of EGF were further dissociated by treatment of cells with the MAP kinase inhibitor PD-98059, which totally blocked the modulatory action of EGF on carbachol-sensitive [Ca 2ϩ ] i signaling ( Fig. 9 ) but did not decrease the acute [Ca 2ϩ ] i response to EGF (data not shown). Growth factor inhibition of carbachol-responsive Ca 2ϩ release also could not be attributed to depletion of internal Ca 2ϩ stores following the rapid [Ca 2ϩ ] i mobilizing action of EGF, because the internal stores were unaltered after prolonged EGF treatment. These observations indicate that the rapid and prolonged [Ca 2ϩ ] i responses to EGF represent distinct and independent actions of the growth factor.
Our results suggest a potential role for EGF in regulation of salivary gland function. EGF modulation of secretory response to muscarinic receptor activation has been reported in salivary gland and other gastrointestinal epithelial tissues. In a previous study examining the effect of EGF on rat parotid gland secretory function, EGF treatment in vivo caused an increase in muscarinic agonist-induced amylase secretion, although no change in salivary flow rate was detected (29) . Other investigations have demonstrated acute inhibitory effects of EGF in vitro on carbachol-stimulated secretory functions in rabbit and canine gastric parietal cells and in human T84 colonic epithelial cells (6, 20, 38, 39) . Whereas EGF inhibition of carbachol responsiveness in parietal cells may be mediated via activation of PKC, the inhibitory actions of EGF in both parietal and colonic cells do not appear to involve modulation of [Ca 2ϩ ] i transients (20, 38, 39) . In contrast to the acute inhibitory effect of EGF on carbachol responsiveness, prolonged EGF treatment of rabbit parietal cells enhances carbachol-stimulated secretory activity. Like the modulatory action of EGF described in the present study of HSY cells, the prolonged effect of EGF in rabbit parietal cells appears to be mediated by the MAP kinase signaling pathway (6) . EGF has also been found to produce acute inhibition, as well as prolonged enhancement, of G protein-coupled receptormediated secretory function in pancreatic acinar cells (28) . Both inhibition and stimulation of G proteincoupled receptor-activated [Ca 2ϩ ] i mobilization have been reported in other cell types after prolonged EGF treatment (13, 22) .
Insofar as EGF is produced and secreted by salivary cells, our findings also raise the possibility that EGF may regulate salivary secretory function through autocrine or paracrine mechanisms. An analogous regulatory role for EGF has been suggested in studies of kidney tubule cells, which produce and secrete EGF and at the same time exhibit a variety of differentiated functions subject to modulation by EGF. Although under baseline conditions renal EGF may be localized to the luminal membrane of tubular epithelial cells, the actions of EGF on sensitive tubule segments are exerted on receptors at the antiluminal, or basolateral, surface. Interestingly, autocrine or paracrine actions of renal EGF may, under some conditions, be facilitated by redistribution of intracellular EGF to the basolateral membrane (24) . Whether the in vivo actions of EGF in salivary cells are subject to similar spatial considerations as exist in kidney epithelial cells is not known. Of note in this regard are recent studies demonstrating EGF-independent transactivation of EGF receptors by muscarinic agonists in human embryonic kidney 293 cells and T84 colonic epithelial cells (17, 37) . In T84 cells, EGF receptor activation has been proposed to function as an inhibitory signal by which a muscarinic agonist negatively regulates its own secretory response (17) . These findings, together with our own observations, suggest that HSY cells may be a useful model to explore the regulation of salivary secretion by spatial and functional interactions between EGF and muscarinic receptor signaling pathways.
In summary, the present study demonstrates that EGF inhibits carbachol-activated [Ca 2ϩ ] i mobilization in the HSY salivary cell line. EGF decreases muscarinic agonist-induced release of Ca 2ϩ from internal stores and also exerts a direct inhibitory action on influx of Ca 2ϩ across the plasma membrane. A decline in muscarinic receptor density may contribute to EGF inhibition of carbachol responsiveness. The inhibitory effect of EGF is mediated by the MAP kinase signaling pathway and is potentiated by a distinct modulatory cascade involving activation of PKC. These data provide the basis for further investigation of possible mechanisms by which cross talk between EGF and muscarinic receptor signaling pathways may function in the physiological regulation of salivary secretion.
